'Carcinoid syndrome' presentation slideshows

{ ??? ???? ?????? ?????? }

{ ??? ???? ?????? ?????? }. Non-Malignant Lung Tumors. ( Surgical point and cases). Dr.Yasser ahmed elsaid ; M.D. Cardiothoracic surgery Air Force Hospital. Classification can be confusing :- Many tumors go by different names Difficult to define benign vs. malignant

1.08k views • 93 slides

{ ??? ???? ?????? ?????? }

{ ??? ???? ?????? ?????? }. Non-Malignant Lung Tumors. ( Surgical point and cases). Dr.Yasser ahmed elsaid ; M.D. Cardiothoracic surgery Air Force Hospital. Classification can be confusing :- Many tumors go by different names Difficult to define benign vs. malignant

1.04k views • 93 slides

The Pathologic classification of Neuroendocrine Tumors

The Pathologic classification of Neuroendocrine Tumors. A.Sadeghipour M.D. Associate Professor of Pathology and Lab. Medicine Iran University of Medical sciences. Why Neuroendocrine Tumors?. 50% OF THE NEUROENDOCRINE TUMORS ARE DIAGNOSED WHEN IN ADVANCED STAGES.

740 views • 72 slides

Adrenals

770 views • 57 slides

CARCINOID TUMORS

1.14k views • 45 slides

GI-NEUROENDOCRINE TUMORS: THERAPEUTIC APPROACHES: SYMPTOMATIC MANAGEMENT

772 views • 44 slides

GI-NEUROENDOCRINE TUMORS: THERAPEUTIC APPROACHES: SYMPTOMATIC MANAGEMENT

449 views • 44 slides

Shiny liver

Dr. Ahmed Refaey. Shiny liver. FRCR. Consultant Radiologist Prince Sultan Military Medical City. Format of the lecture. Detection of liver masses by CT Hypervascular tumors of the liver Case of the day. Detection of liver masses by CT. * Triphasic study * arterial phase

423 views • 41 slides

Rectal Carcinoid Current Management and Evidence

Shannon Chan Prince of Wales Hospital. Rectal Carcinoid Current Management and Evidence. Case Scenario. F/47 Ms Ying Good past health Screening colonoscopy by private: 1.5cm rectal polyp at 5cm from anal verge Polyp base elevated with NS and snared Path: Carcinoid, Margin involved.

384 views • 35 slides

Dr. Christos Toumpanakis MD PhD FRCP Consultant in Gastroenterology/Neuroendocrine Tumours

Dr. Christos Toumpanakis MD PhD FRCP Consultant in Gastroenterology/Neuroendocrine Tumours Hon. Senior Lecturer University College of London Neuroendocrine Tumour Unit - ENETS Centre of Excellence ROYAL FREE HOSPITAL, London,UK. NET MASTERCLASS

317 views • 27 slides

Laparoscopic Gastric Resections

Laparoscopic Gastric Resections. Dmitry Oleynikov M.D, F.A.C.S Associate Professor of Surgery Joseph and Richard Still Faculty Fellow in Medicine Director of Minimally Invasive And Robotic Surgery University Of Nebraska School Of Medicine. Major Contributors to Adoption Laparoscopic Approach.

511 views • 23 slides

Defending Diagnoses

Defending Diagnoses. Carcinoid Tumor (11): Jack Mbabuike Colon Adenocarcinoma (3): Joshua Gordon Basal Cell Carcinoma (1): Owen Dubowy Hepatocellular Carcinoma (1): Amer Assal Other Diagnoses: Pheochromocytoma VIPoma Gastric Cancer Gastrinoma. Liver Biopsy.

387 views • 20 slides

Defending Diagnoses

Defending Diagnoses. Carcinoid Tumor (11): Jack Mbabuike Colon Adenocarcinoma (3): Joshua Gordon Basal Cell Carcinoma (1): Owen Dubowy Hepatocellular Carcinoma (1): Amer Assal Other Diagnoses: Pheochromocytoma VIPoma Gastric Cancer Gastrinoma. Liver Biopsy.

435 views • 20 slides

Case Report Brian Kurtz D.O. PGY-2 11/5/10

335 views • 19 slides

Small Bowel Tumors

Small Bowel Tumors. Keith D. Lillemoe M.D. Dept. of Surgery Indiana University School of Medicine. Small Bowel Tumors. Epidemiology. Exceedingly rare - < 5500 new cases,1200 deaths/year Explanations lack of bacteria rapid transit role of pancreatic and mucosal enzymes

480 views • 18 slides

Neuroendocrine Tumors

Neuroendocrine Tumors. James C. Yao, MD Associate Professor Deputy Chairman, Gastrointestinal Medical Oncology University of Texas M. D. Anderson Cancer Center. Neuroendocrine Tumors. Spectrum of neoplasms. WHO classification Well differentiated neuroendocrine tumor

1.79k views • 10 slides

Facts & Figures of lx1606 | EOS MED CHEM

Chemical name of LX1606 is Telotristat etiprate. It is an oral serotonin synthesis inhibitor or peripheral tryptophan hydroxylase (TPH) inhibitor. LX1606 drug is used in diarrhea disease related with carcinoid syndrome. See drug info @ http://www.eosmedchem.com/1137608-69-5.html

195 views • 7 slides

Carcinoid Syndrome Diarrhea Treatment Market Opportunity Analysis, 2026

Carcinoid syndrome is caused by secretion of certain harmful chemicals by carcinoid tumors. Carcinoid syndrome may occur due to infection or other related diseases, and medical or surgical treatments such as anesthesia, chemotherapy, embolization, and tumor debulking. The key symptoms of the syndrome include flushing of the skin and diarrhea, rapid heartbeat, and bronchoconstriction. If remained undiagnosed, it could lead to several complications such as weight loss, electrolyte imbalance, dehydrations, menopause, irritable bowel disease, and asthma.

64 views • 3 slides

Carcinoid Syndrome Diarrhea Treatment Market Opportunity Analysis, 2026

Development of first-of-its-kind therapeutic approach to treat carcinoid syndrome diarrhea creates highly lucrative growth opportunities for market players.

56 views • 3 slides

INTRODUCTION A 56 year old woman was referred with persistent facial flushing symptoms.

DISCUSSION Carcinoid tumours are of neuroendocrine cell origin and are slowly progressive tumours that produce serotonin and tachykinins that can occur in the gastrointestinal tract, ovaries, testis and bronchi.

212 views • 1 slides